NCT06807008View on ClinicalTrials.gov

A Novel Pathway to Detect Muscle-invasive Bladder Cancer Based on Integrated Clinical Features and VI-RADS Score on MRI

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Muscle Invasive Bladder Cancer
Trial Locations (4)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

Unknown

AOU Policlinico Umberto I - Sapienza University of Rome, Roma

"Regina Elena National Cancer Institute", Roma

Santa Maria della Misericordia University Hospital in Udine, Udine

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06807008 - A Novel Pathway to Detect Muscle-invasive Bladder Cancer Based on Integrated Clinical Features and VI-RADS Score on MRI | Biotech Hunter | Biotech Hunter